AB Corporate Valuation
| EYEG Etf | USD 36.29 0.18 0.50% |
At this time, the entity appears to be fairly valued. AB Corporate Bond owns a latest Real Value of $36.28 per share. The recent price of the entity is $36.29. Our model approximates the value of AB Corporate Bond from evaluating the entity fundamentals such as Shares Owned By Institutions of 24.20 %, number of shares shorted of 54.54 K, and Return On Asset of -40.35 as well as inspecting its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that AB Corporate's price fluctuation is very steady at this time. Calculation of the real value of AB Corporate Bond is based on 3 months time horizon. Increasing AB Corporate's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the EYEG etf is determined by what a typical buyer is willing to pay for full or partial control of AB Corporate Bond. Since AB Corporate is currently traded on the exchange, buyers and sellers on that exchange determine the market value of EYEG Etf. However, AB Corporate's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 36.29 | Real 36.28 | Hype 36.29 | Naive 36.41 |
The real value of EYEG Etf, also known as its intrinsic value, is the underlying worth of AB Corporate Bond ETF, which is reflected in its stock price. It is based on AB Corporate's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of AB Corporate's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of AB Corporate Bond helps investors to forecast how EYEG etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AB Corporate more accurately as focusing exclusively on AB Corporate's fundamentals will not take into account other important factors: AB Corporate Total Value Analysis
AB Corporate Bond is currently forecasted to have valuation of 18.1 M with market capitalization of 13.84 M, debt of 308.01 K, and cash on hands of 3.66 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the AB Corporate fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
18.1 M | 13.84 M | 308.01 K | 3.66 M |
AB Corporate Investor Information
AB Corporate is is formed as Regulated Investment Company in the United States. ETF is managed and operated by State Street Bank and Trust Company. The fund has 398 constituents across multiple sectors and instustries. The fund charges 0.3 percent management fee with a total expences of 0.3 percent of total asset. Based on the measurements of operating efficiency obtained from AB Corporate's historical financial statements, AB Corporate Bond is not in a good financial situation at the present time. It has a very high likelihood of going through financial trouble in January.AB Corporate Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. AB Corporate has an asset utilization ratio of 0.11 percent. This implies that the ETF is making $0.001136 for each dollar of assets. An increasing asset utilization means that AB Corporate Bond is more efficient with each dollar of assets it utilizes for everyday operations.AB Corporate Ownership Allocation
The market capitalization of AB Corporate Bond is $13.84 Million. AB Corporate Bond owns 12.18 % of its outstanding shares held by insiders and 24.2 % owned by institutions. Note, that even with negative profits, if the true value of the entity is larger than the current market value, you may still be able to generate positive returns on investment in this company.AB Corporate Profitability Analysis
The company reported the previous year's revenue of 12.06 K. Net Loss for the year was (9.47 M) with loss before overhead, payroll, taxes, and interest of (3.55 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates AB Corporate's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in AB Corporate and how it compares across the competition.
About AB Corporate Valuation
The etf valuation mechanism determines AB Corporate's current worth on a weekly basis. Our valuation model uses a comparative analysis of AB Corporate. We calculate exposure to AB Corporate's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of AB Corporate's related companies.EyeGate Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing products for treating inflammatory and immune diseases with a focus on the eye and nervous system in the United States. Eyegate Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Waltham, Massachusetts. Eyegate Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in AB Corporate Bond. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
The market value of AB Corporate Bond is measured differently than its book value, which is the value of EYEG that is recorded on the company's balance sheet. Investors also form their own opinion of AB Corporate's value that differs from its market value or its book value, called intrinsic value, which is AB Corporate's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AB Corporate's market value can be influenced by many factors that don't directly affect AB Corporate's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AB Corporate's value and its price as these two are different measures arrived at by different means. Investors typically determine if AB Corporate is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AB Corporate's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.